More than 12,000 pregnant patients in the United States per year have
conditions normally evaluated by esophagogastroduodenoscopy (EGD). Mor
e than 6000 pregnant patients in the United States per year have condi
tions normally evaluated by sigmoidoscopy or colonoscopy. Endoscopy du
ring pregnancy raises the unique issue of fetal safety, and endoscopic
medications comprise a significant component of fetal risks from endo
scopy. This article analyzes the safety of endoscopic medications duri
ng pregnancy, reviews the literature on the safety of gastrointestinal
endoscopy during pregnancy, proposes guidelines for endoscopic indica
tions during pregnancy, and describes modifications of gastrointestina
l endoscopy during pregnancy to increase fetal and maternal safety.